FDA Update On Bausch And Lomb Lens Solution Recall. The Food and Drug Administration Monday gave an update on Bausch & Lomb’s probe into its ReNu lens solution’s link to infection.
In a statement, the FDA said it met with Bausch & Lomb May 11 to get information on the company’s internal investigation into several cases of the eye infection Fusarium keratitis associated with the contact-lens solution ReNu with MoistureLoc.
The FDA said, “Bausch & Lomb has proposed that unique characteristics of the formulation of the ReNu with MoistureLoc product in certain unusual circumstances can increase the risk of Fusarium infection,” an infection that can cause blindness if not treated.
ReNu With MoistureLoc May Increase Fusarium
“Based on this scientific and epidemiological data suggesting that ReNu with MoistureLoc may increase susceptibility to Fusarium, Bausch & Lomb has decided to permanently remove the ReNu with MoistureLoc product worldwide,” the FDA said. The agency said it supported the company’s decision.
“To date, data available do not indicate a problem with ReNu MultiPlus or ReNu Multi-Purpose or generic brands of this contact lens cleaning solution,” the agency added.